. 2024 Jun 11;15:1365700. doi: 10.3389/fendo.2024.1365700
Copyright © 2024 Klinc, Groselj, Mlinaric, Homan, Markelj, Mezek Novak, Sirca Campa, Sikonja, Battelino, Zerjav Tansek and Drole Torkar
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 2.
Evolution of body mass index (BMI) during empagliflozin treatment.